3,200
Participants
Start Date
September 6, 2024
Primary Completion Date
March 1, 2027
Study Completion Date
March 1, 2027
Refer2Quit
The Refer2Quit intervention consists of automatic connection to the adult participant's choice of any or all of four evidence-based tobacco treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), as well as motivational counseling provided by the study team. Supportive and motivational text messaging is also included in the intervention to connect or reconnect adult participants to treatments as needed. Text messaging and support would also focus on supporting appropriate use of NRT and/or varenicline if indicated.
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Children's Hospital of Philadelphia
OTHER